Cite
MLA Citation
Cameron Chalker et al.. “Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.” Cancer medicine, vol. 11, 2022, pp. 4104–4111. http://access.bl.uk/ark:/81055/vdc_100170099853.0x000010